Literature DB >> 12207173

Didemnin B induces apoptosis in proliferating but not resting peripheral blood mononuclear cells.

M A Baker1, D R Grubb, A Lawen.   

Abstract

We have previously shown that didemnin B, a branched cyclic depsipeptide composed of seven amino acids and two hydroxy acids, can induce rapid and complete apoptosis in HL-60 cells (Grubb, D.R. et al. (1995) Biochem. Biophys. Res. Commun. 215, 1130-1136). We now report that didemnin B can induce apoptosis in a wide range of transformed cell lines. Resting normal lymphocytes, however, are apparently unaffected by exposure to the drug. To investigate whether cell transformation, and/or cell proliferation is necessary for didemnin B to induce apoptosis, we examined the effect of didemnin B on freshly harvested human lymphocytes before and after stimulation with concanavalin A. Didemnin B induced apoptosis in normal lymphocytes only after mitogenic stimulation and therefore warrants further examination for its potential as a chemotherapeutic agent, especially for treatment of leukemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12207173     DOI: 10.1023/a:1020078907108

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  6 in total

Review 1.  Drug development from marine natural products.

Authors:  Tadeusz F Molinski; Doralyn S Dalisay; Sarah L Lievens; Jonel P Saludes
Journal:  Nat Rev Drug Discov       Date:  2008-12-19       Impact factor: 84.694

2.  Didemnin B and ternatin-4 differentially inhibit conformational changes in eEF1A required for aminoacyl-tRNA accommodation into mammalian ribosomes.

Authors:  Manuel F Juette; Jordan D Carelli; Emily J Rundlet; Alan Brown; Sichen Shao; Angelica Ferguson; Michael R Wasserman; Mikael Holm; Jack Taunton; Scott C Blanchard
Journal:  Elife       Date:  2022-10-20       Impact factor: 8.713

3.  Synthesis, cytotoxicity and apoptosis induction in human tumor cells by galaxamide and its analogues [corrected].

Authors:  Xi Xiao; Xiaojian Liao; Shaoling Qiu; Zihao Liu; Bin Du; Shihai Xu
Journal:  Mar Drugs       Date:  2014-08-18       Impact factor: 5.118

Review 4.  Natural Products Diversity of Marine Ascidians (Tunicates; Ascidiacea) and Successful Drugs in Clinical Development.

Authors:  Satheesh Kumar Palanisamy; N M Rajendran; Angela Marino
Journal:  Nat Prod Bioprospect       Date:  2017-01-17

Review 5.  Anticancer Activity of Natural Compounds from Plant and Marine Environment.

Authors:  Anna Lichota; Krzysztof Gwozdzinski
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923

Review 6.  From Seabed to Bedside: A Review on Promising Marine Anticancer Compounds.

Authors:  Edina Wang; Maria Alba Sorolla; Priya Darshini Gopal Krishnan; Anabel Sorolla
Journal:  Biomolecules       Date:  2020-02-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.